China Pioneer Pharma Holdings Limited

Symbol: 1345.HK

HKSE

1.42

HKD

Market price today

  • 13.7445

    P/E Ratio

  • 0.0000

    PEG Ratio

  • 1.67B

    MRK Cap

  • 0.04%

    DIV Yield

China Pioneer Pharma Holdings Limited (1345-HK) Financial Statements

On the chart you can see the default numbers in dynamics for China Pioneer Pharma Holdings Limited (1345.HK). Companys revenue shows the average of NaN M which is NaN % gowth. The average gross profit for the whole period is NaN M which is NaN %. The average gross profit ratio is NaN %. The net income growth for the company last year performance is NaN % which equals NaN % % on average for the whole company history.,

Balance Sheet

Diving into the fiscal trajectory of China Pioneer Pharma Holdings Limited, we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to . A look back at the past year reveals a total asset change of NaN. Shareholder value, as depicted by the total shareholder equity, is valued at NaN in the reporting currency. The year over year change in this aspect is NaN%.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012

balance-sheet.row.cash-and-short-term-investments

0124.4289402.1
254.6
468.8
197.9
276.2
309.6
317.1
260.8
781.9
59.6

balance-sheet.row.short-term-investments

01075177.2
139.6
198.5
47
50
0
0
10
60
0

balance-sheet.row.net-receivables

0448.4413.2251.8
288
269.6
310.3
526.6
450.7
413.6
545
316.6
511.5

balance-sheet.row.inventory

0417.9321.1294.9
448.7
393.6
419.7
623.4
520.2
663.2
620
419.8
295.9

balance-sheet.row.other-current-assets

0126.2186.6241.5
275.4
300.6
202.4
103.7
128.5
143.5
585.4
343.5
0.1

balance-sheet.row.total-current-assets

01106.91134.91013.1
1127.1
1234.1
1083.2
1529.8
1409.1
1537.5
2011.2
1842
867

balance-sheet.row.property-plant-equipment-net

0247.4221.691.1
80.8
55.2
46.1
52.3
49.9
76.5
103.7
17.2
11.3

balance-sheet.row.goodwill

06.26.20
0
0
0
0
0
0
42.3
0
0

balance-sheet.row.intangible-assets

030.23745.9
47
12
14.1
15.2
15.9
61.2
158.4
15.2
18.2

balance-sheet.row.goodwill-and-intangible-assets

036.443.345.9
47
12
14.1
15.2
15.9
61.2
200.7
15.2
18.2

balance-sheet.row.long-term-investments

0117.1156.282.2
80.7
139.2
52.8
92.1
109.2
67.1
65.2
77
0

balance-sheet.row.tax-assets

02.38.612
19.5
7.8
8.6
5.4
5.9
2.1
2.3
2.1
6.3

balance-sheet.row.other-non-current-assets

020.7-8.6-12
-19.5
-7.8
-8.6
-5.4
-5.9
-2.1
-2.3
-2.1
25.7

balance-sheet.row.total-non-current-assets

0424421219.2
208.5
206.4
113
159.6
175
204.8
369.6
109.4
61.6

balance-sheet.row.other-assets

0015.896.1
92.8
110.1
241.6
144.6
164.4
79.8
174
45.5
0

balance-sheet.row.total-assets

01530.91571.71328.5
1428.4
1550.6
1437.8
1834
1748.5
1822
2554.9
1996.9
928.6

balance-sheet.row.account-payables

0284.9329.3262
360.7
263.5
143.3
568.9
419.7
426.1
391.8
329.2
244.4

balance-sheet.row.short-term-debt

061.329.614
15.1
49
101.1
34.3
79.4
287.9
611.1
429.5
416.2

balance-sheet.row.tax-payables

017.839.824.9
31.8
31.3
14.5
16.4
28.6
14.8
14.7
7.3
6

balance-sheet.row.long-term-debt-total

012.780.1
0
0.1
0
4.8
11.2
15.3
8.6
0.5
0

Deferred Revenue Non Current

041.443.643.6
19.4
-7.4
0
0
1.5
0.6
0
-7
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

00143.586.2
123.7
135.6
186.7
110.2
175
350.1
830.8
476.3
0.5

balance-sheet.row.total-non-current-liabilities

070.476.369.3
32.3
7.5
2
13.9
43.2
49.4
106.3
0.5
660.6

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
33.6
-660.6

balance-sheet.row.capital-lease-obligations

0148.70.2
0
0.2
4.6
10.1
14.4
17.3
9.3
26.1
0

balance-sheet.row.total-liab

0513.1549.2417.5
516.7
406.6
332
693
637.9
825.6
1328.9
839.6
715.7

balance-sheet.row.preferred-stock

0084.159
214.2
150.1
101.8
69.3
75.7
94.4
93.1
57.1
0

balance-sheet.row.common-stock

077.477.477.6
77.6
77.6
79.1
81.4
82.1
82.1
82.1
82.1
0

balance-sheet.row.retained-earnings

0634.9594.8444.2
590.5
538
433.4
361.5
297.9
202.9
181.3
175.6
88.5

balance-sheet.row.accumulated-other-comprehensive-income-loss

0929-84.1-59
-214.2
-150.1
-101.8
-69.3
-75.7
-94.4
-93.1
-57.1
-7.1

balance-sheet.row.other-total-stockholders-equity

0-634.9335.6386.2
241.4
526
592.1
766.5
806.6
807.5
957
957
130.7

balance-sheet.row.total-stockholders-equity

01006.41007.8908
909.4
1141.5
1104.6
1140.1
1110.9
998.1
1127.4
1157.6
212.1

balance-sheet.row.total-liabilities-and-stockholders-equity

01530.91571.71328.5
1428.4
1550.6
1437.8
1834
1748.5
1822
2554.9
1996.9
928.6

balance-sheet.row.minority-interest

011.314.73
2.3
2.4
1.3
0.9
-0.3
-1.6
98.6
-0.3
0.8

balance-sheet.row.total-equity

01017.81022.5911
911.7
1144
1105.9
1141.1
1110.6
996.4
1226
1157.3
212.8

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-

Total Investments

0117.1231.2259.4
220.3
337.8
99.8
142.1
109.2
67.1
65.2
137
14.2

balance-sheet.row.total-debt

07437.614.1
15.1
49
101.1
39.1
90.7
303.2
619.7
429.5
416.2

balance-sheet.row.net-debt

0-40.4-176.4-210.8
-99.9
-221.3
-49.7
-187
-219
-13.9
358.9
-272.5
356.7

Cash Flow Statement

The financial landscape of China Pioneer Pharma Holdings Limited has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of NaN. The company recently extended its share capital by issuing NaN, marking a difference of NaN compared to the previous year. The company's investing activities resulted in net cash usage, amounting to NaN in the reporting currency. This is a shift of NaN from the previous year. In the same period, the company recorded NaN, NaN, and NaN, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of NaN, with a year over year difference of NaN. Furthermore, the company allocated NaN for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as NaN, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM2022202120202019201820172016201520142013201220112010

cash-flows.row.net-income

0235.3142.652.4
104.6
84.6
278.9
237.4
174.3
261.7
238.4
206.8
123.1
96.9

cash-flows.row.depreciation-and-amortization

013.612.98.4
8.9
8.1
8.3
13.2
16.9
7.6
2.5
2.8
2.5
2

cash-flows.row.deferred-income-tax

0000
0
-385.2
194.6
-94.5
-35.1
0
0
0
0
0

cash-flows.row.stock-based-compensation

0000
0
0
-1.4
0.9
0.6
0
0
0
0
0

cash-flows.row.change-in-working-capital

0-193.5226.3-147.3
4.8
385.3
-193.1
93.6
34.5
-296.2
-257.6
-47.7
-123.5
-1.2

cash-flows.row.account-receivables

0-16866.2-65.3
-20
180.5
-78.2
-6.7
111.6
-168.6
-130.8
0
0
0

cash-flows.row.inventory

0-25.5160.2-82.1
24.9
204.7
-114.9
100.3
-77.1
-127.6
-126.8
-56.3
-135.3
2.7

cash-flows.row.account-payables

0000
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0000
0
0
0
0
0
0
0
8.6
11.8
-3.8

cash-flows.row.other-non-cash-items

037.9-139.8160.8
162.3
36
141
-3.1
78.4
9.1
64.7
-41.2
-23.9
-26.5

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-74.3-16.6-34.9
-8.9
-0.4
-9.7
-5.2
-6.1
-39.5
-16
-12.5
-4.7
-1.3

cash-flows.row.acquisitions-net

0-26.7-2.4-20.9
0.7
-7.8
-2
-62.1
-36.1
-110.6
-28.3
0
0
0

cash-flows.row.purchases-of-investments

0-717.2-2020.3-512.9
-697.9
-270.9
-50
0
-29.6
-78.1
-115.6
-15.7
0
0

cash-flows.row.sales-maturities-of-investments

0798.11976.4570.5
542.4
50
52
0
75.2
80
143.9
0
0
0

cash-flows.row.other-investing-activites

0771.422.1
81.1
30.4
49.7
61.2
417.5
-200.6
47.3
0.7
-142.6
47.3

cash-flows.row.net-cash-used-for-investing-activites

0-138.423.9
-82.6
-198.6
-12.1
-6.1
420.9
-348.7
-112.6
-27.5
-147.3
45.9

cash-flows.row.debt-repayment

0-1.10-0.1
-4.7
-61
-127.3
-483.5
-1103.2
-663.9
-484.8
-338
-142.9
-191.5

cash-flows.row.common-stock-issued

026.910.4-2.8
0
-1.9
-15.4
-0.9
-149.5
0
1097.9
0
0
0

cash-flows.row.common-stock-repurchased

0-25.8-10.3-2.8
-19.4
-74.9
-40.8
-0.9
-149.5
0
-383.5
0
0
0

cash-flows.row.dividends-paid

0-84.7-129.9-111.9
0
-137.8
-215.3
-142.5
-187.8
-256
-229.6
-147.6
-90
-36

cash-flows.row.other-financing-activites

0-6.4-10.4-135.5
-54.4
270.7
95.4
280.9
918.4
848.9
323
400.5
339.2
142.9

cash-flows.row.net-cash-used-provided-by-financing-activities

0-91-140.3-253
-78.5
-4.8
-303.3
-346.9
-671.6
-71
706.5
-85.1
106.3
-84.6

cash-flows.row.effect-of-forex-changes-on-cash

0-0.1-0.3-0.4
0
-0.5
-1.7
3.5
2.2
-3.8
0.7
0
-0.2
0

cash-flows.row.net-change-in-cash

0-10.8109.8-155.3
119.4
-75.3
-83.5
-7.5
56.3
-441.2
642.5
8.2
-63
32.5

cash-flows.row.cash-at-end-of-period

0214224.9115
270.3
150.9
226.2
309.6
317.1
260.8
702.1
59.6
51.4
114.3

cash-flows.row.cash-at-beginning-of-period

0224.9115270.3
150.9
226.2
309.6
317.1
260.8
702.1
59.6
51.4
114.3
81.9

cash-flows.row.operating-cash-flow

093.3242.174.2
280.6
128.7
233.6
342
304.7
-17.8
47.9
120.8
-21.8
71.2

cash-flows.row.capital-expenditure

0-74.3-16.6-34.9
-8.9
-0.4
-9.7
-5.2
-6.1
-39.5
-16
-12.5
-4.7
-1.3

cash-flows.row.free-cash-flow

019225.439.4
271.8
128.3
223.9
336.8
298.5
-57.3
31.9
108.3
-26.5
69.9

Income Statement Row

China Pioneer Pharma Holdings Limited's revenue saw a change of NaN% compared with the previous period. The gross profit of 1345.HK is reported to be NaN. The company's operating expenses are NaN, showing a change of NaN% from the last year. The expenses for depreciation and amortization are NaN, which is a NaN% change from the last accounting period. Operating expenses are reported to be NaN, which shows a NaN% year-over-year change. Selling and marketing expenses are NaN, which is a NaN% change compared to the previous year. The EBITDA based on the recent numbers is NaN, representing a NaN% year-over-year growth. The operating income is NaN, which shows a NaN% change when compared to the previous year. The change in the net income is NaN%. The net income for the last year was NaN.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010

income-statement-row.row.total-revenue

01566.715561434.8
1332
1316
1624.3
2153.9
1790.3
1460.9
1540.4
1272.2
958.7
717.8
570.6

income-statement-row.row.cost-of-revenue

0898.4775.6662.8
724.1
636.2
991.9
1432.5
1196.9
998.3
1048.4
885.6
652
522.1
404.6

income-statement-row.row.gross-profit

0668.2780.5772
608
679.8
632.4
721.4
593.4
462.6
491.9
386.6
306.7
195.7
166.1

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

01.64.82.7
2.9
8.5
8.7
5.3
4
5.3
4.8
1.3
0.8
0.6
0.3

income-statement-row.row.operating-expenses

0488496.6574.6
519
543.3
541.6
428.4
324
276.8
210.3
113.5
109.4
79.1
71.1

income-statement-row.row.cost-and-expenses

01386.51272.11237.4
1243
1179.5
1533.5
1860.9
1520.8
1275.1
1258.7
999.1
761.4
601.2
475.6

income-statement-row.row.interest-income

00.610.64
6.3
12
16.3
16.3
12.9
21
23
0.7
14.4
7.5
5.8

income-statement-row.row.interest-expense

02.51.70.9
1.1
4
1.4
2.3
5.5
20
14.1
12.7
9.4
5.5
5

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

046.962.314.2
22.2
10
-42.5
24.7
39.8
-53.7
20.4
21.2
-7.8
-2.1
-5.3

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

01.64.82.7
2.9
8.5
8.7
5.3
4
5.3
4.8
1.3
0.8
0.6
0.3

income-statement-row.row.total-operating-expenses

046.962.314.2
22.2
10
-42.5
24.7
39.8
-53.7
20.4
21.2
-7.8
-2.1
-5.3

income-statement-row.row.interest-expense

02.51.70.9
1.1
4
1.4
2.3
5.5
20
14.1
12.7
9.4
5.5
5

income-statement-row.row.depreciation-and-amortization

018.913.212.7
8.1
8.7
8.1
8.3
13.2
16.9
7.6
2.5
2.8
2.5
2

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0133.5232.2187.2
73.1
138.5
149.7
284.6
242.6
260.5
284.3
251.3
214.6
125.1
102.1

income-statement-row.row.income-before-tax

0180.4294.5201.4
95.3
148.5
107.1
309.3
282.4
206.8
304.7
272.5
206.8
123.1
96.9

income-statement-row.row.income-tax-expense

051.564.560.6
43.9
44.6
22.3
28.7
43.7
34.3
43.7
36.7
21.1
26.1
21.8

income-statement-row.row.net-income

0145.7235.3142.6
52.4
104.6
84.6
278.9
237.4
174.3
261.7
238.4
186.4
95.7
70.4

Frequently Asked Question

What is China Pioneer Pharma Holdings Limited (1345.HK) total assets?

China Pioneer Pharma Holdings Limited (1345.HK) total assets is 1530905000.000.

What is enterprise annual revenue?

The annual revenue is N/A.

What is firm profit margin?

Firm profit margin is 0.427.

What is company free cash flow?

The free cash flow is -0.127.

What is enterprise net profit margin?

The net profit margin is 0.093.

What is firm total revenue?

The total revenue is 0.085.

What is China Pioneer Pharma Holdings Limited (1345.HK) net profit (net income)?

The net profit (net income) is 145718000.000.

What is firm total debt?

The total debt is 74020000.000.

What is operating expences number?

The operating expences are 488030000.000.

What is company cash figure?

Enretprise cash is 0.000.